Sandbox Reserved 1488
From Proteopedia
(Difference between revisions)
Line 2: | Line 2: | ||
==Enterococcus faecalis Penicillin Binding Protein 4 (PBP4)== | ==Enterococcus faecalis Penicillin Binding Protein 4 (PBP4)== | ||
<StructureSection load='6bsq' size='340' side='right' caption='Caption for this structure' scene=''> | <StructureSection load='6bsq' size='340' side='right' caption='Caption for this structure' scene=''> | ||
- | + | Penicillin-binding proteins (PBPs) have been scrutinized for over 40 years. Recent structural information on PBPs together with the ongoing long-term biochemical experimental investigations, and results from more recent techniques such as protein localization by green fluorescent protein-fusion immunofluorescence or double-hybrid assay, have brought our understanding of the last stages of the peptidoglycan biosynthesis to an outstanding level that allows a broad outlook on the properties of these enzymes. Details are emerging regarding the interaction between the peptidoglycan-synthesizing PBPs and the peptidoglycan, their mesh net-like product that surrounds and protects bacteria<ref>DOI:10.1111/j.1574-6976.2008.00105.x</ref>. | |
- | + | ||
==Function == | ==Function == | ||
Line 10: | Line 10: | ||
PBPs are classified by their enzymatic activity: | PBPs are classified by their enzymatic activity: | ||
(1) class A, bifunctional PBPs with both glycosyltransferase and transpeptidase activities; | (1) class A, bifunctional PBPs with both glycosyltransferase and transpeptidase activities; | ||
+ | |||
(2) class B, transpeptidases; and | (2) class B, transpeptidases; and | ||
+ | |||
(3) class C, carboxy-peptidases and endopeptidases. | (3) class C, carboxy-peptidases and endopeptidases. | ||
- | |||
- | |||
== Disease == | == Disease == | ||
+ | Enterococci exhibits tolerance to the bactericidal activity of β-lactams <ref>DOI:10.1172/JCI106758</ref> , a phenomenon that compromises the use of β-lactam antibiotics as single agents in the treatment of enterococcal endocarditis <ref>DOI: 10.1056/NEJM196603312741304</ref>. As a consequence, multi-resistant E. faecium and E. faecalis represent one of the most dangerous threats in infectious diseases therapeutics. | ||
+ | |||
+ | Rare strains of E. faecalis and most nosocomial strains of E. faecium exhibit even higher levels of resistance to penicillins, effectively eliminating β-lactams as a treatment option <ref>doi: 10.1086/533452</ref>. Of greater concern is the observation that prolonged β-lactam therapy can lead to the emergence of highly resistant strains. | ||
== Structure == | == Structure == |
Revision as of 13:30, 10 January 2019
This Sandbox is Reserved from 06/12/2018, through 30/06/2019 for use in the course "Structural Biology" taught by Bruno Kieffer at the University of Strasbourg, ESBS. This reservation includes Sandbox Reserved 1480 through Sandbox Reserved 1543. |
To get started:
More help: Help:Editing |
Enterococcus faecalis Penicillin Binding Protein 4 (PBP4)
|
References
- ↑ Sauvage E, Kerff F, Terrak M, Ayala JA, Charlier P. The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis. FEMS Microbiol Rev. 2008 Mar;32(2):234-58. doi: 10.1111/j.1574-6976.2008.00105.x., Epub 2008 Feb 11. PMID:18266856 doi:http://dx.doi.org/10.1111/j.1574-6976.2008.00105.x
- ↑ Moellering RC Jr, Weinberg AN. Studies on antibiotic syngerism against enterococci. II. Effect of various antibiotics on the uptake of 14 C-labeled streptomycin by enterococci. J Clin Invest. 1971 Dec;50(12):2580-4. doi: 10.1172/JCI106758. PMID:5001959 doi:http://dx.doi.org/10.1172/JCI106758
- ↑ Jawetz E, Sonne M. Penicillin-streptomycin treatment of enterococcal endocarditis. A re-evaluation. N Engl J Med. 1966 Mar 31;274(13):710-5. doi: 10.1056/NEJM196603312741304. PMID:5908873 doi:http://dx.doi.org/10.1056/NEJM196603312741304
- ↑ Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis. 2008 Apr 15;197(8):1079-81. doi: 10.1086/533452. PMID:18419525 doi:http://dx.doi.org/10.1086/533452